| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |